• Open Access

Report of the first Asia-Pacific influenza summit, Asia-Pacific Alliance for the Control of Influenza (APACI), Bangkok, 12–13 June 2012


  • Lance C. Jennings,

    Corresponding author
    1. Canterbury Health Laboratories, Christchurch, New Zealand
    2. The University of Otago, Christchurch, New Zealand
    • Correspondence: Lance C. Jennings, Canterbury Health Laboratories, Department of Microbiology, P.O. Box 151, Christchurch 8011, New Zealand. E-mail: lance.jennings@cdhb.health.nz

    Search for more papers by this author
  • David W. Smith,

    1. Division of Microbiology and Infectious Diseases, PathWest QEII Medical Centre, Perth, WA, Australia
    2. Faculty of Medicine, Dentistry and Health Sciences, School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA, Australia
    Search for more papers by this author
  • Paul K. S. Chan

    1. Department of Microbiology, Chinese University of Hong Kong, Hong Kong SAR, China
    Search for more papers by this author


On June 12-13, 2012, the Asia-Pacific Alliance for the Control of Influenza (APACI) convened jointly with the Influenza Foundation of Thailand and the Thailand Department of Disease Control, the First Asia-Pacific Influenza Summit. The objectives of the meeting were to review the current state of official influenza control policies in Asia-Pacific countries; identify, summarize and communicate influenza control strategies that have successfully increased vaccine uptake in the region; develop policy and advocacy approaches to improve influenza vaccine uptake in high-risk groups and healthcare workers in the region; and establish collaborative relationships to promote best practices for the control of influenza. In moving forward, the challenge for the region will be establishing collaborations able to effectively communicate risk and key messages about influenza vaccination.